Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)Fecal Microbiota Transplantation
Interventions
PROCEDURE

Fecal microbiota transplantation

Fecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota.

DRUG

infliximab

Intravenous infusion of infliximab once every 8 weeks.

Trial Locations (1)

Unknown

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER